High materiality8/10
Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings
Why it may matterVerify against the original reporting
Despite expected losses, revenue growth and analyst upgrades support a positive outlook.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
ANGO to report Q1 earnings on October 2. Projected loss of 12 cents per share indicates potential ongoing challenges. Quarterly revenue expected to rise to $72.69 million, showing growth. Analysts maintain Buy ratings, projecting targets from $16 to $17. Shares rose 4% to $11.17 prior to earnings release.
- ANGO to report Q1 earnings on October 2.
- Projected loss of 12 cents per share indicates potential ongoing challenges.
- Quarterly revenue expected to rise to $72.69 million, showing growth.
- Analysts maintain Buy ratings, projecting targets from $16 to $17.
- Shares rose 4% to $11.17 prior to earnings release.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.